BLSMBlossomHill Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of BlossomHill Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLSM본 종목 | — | — | — | — | — | — | — | — | — | — | — | — |
| BGM | — | — | — | — | 51.1%#1 | -1282.1%#4 | -33.2%#2 | -5.1%#1 | — | — | -96.3%#2 | — |
| BHST | $55M#1 | — | 2.2x#1 | 1.6x#1 | 37.0%#2 | 13.8%#2 | -16.2%#1 | -43.8%#2 | -216.8%#1 | — | -69.2%#1 | — |
| BIOM | — | — | — | — | — | 16.6%#1 | — | — | — | — | — | — |
| BIXT | — | — | — | — | -22.5%#3 | 10.3%#3 | -964.3%#3 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-09.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice